Stocks AIN Financial statements
Financial statementsALBANY INTERNATIONAL CORP /DE/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALBANY INTERNATIONAL CORP /DE/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 780 | 864 | 982 | 1,054 | 901 | 929 | 1,035 | 1,148 | 1,231 | 1,183 |
| Cost of revenue | 479 | 567 | 633 | 656 | 530 | 551 | 645 | 724 | 829 | 939 |
| Gross profit | 301 | 296 | 350 | 398 | 371 | 378 | 390 | 424 | 402 | 244 |
| Research and development | 28.8 | 30.7 | 29.8 | 26.9 | 25.8 | 38.9 | 39.9 | 40.6 | ||
| Selling, general and administrative | 158 | 163 | 156 | 164 | 164 | 160 | 169 | 215 | 211 | 218 |
| General and administrative | 53.7 | 56.8 | 73.1 | |||||||
| Operating income | 94.1 | 78.7 | 137 | 194 | 166 | 178 | 181 | 168 | 131 | -36.1 |
| Interest expense | 15.5 | 18.6 | 20.2 | 19.7 | 16.3 | 17.4 | 17.8 | 20.2 | 16.6 | 25.8 |
| Interest income | 2.08 | 1.51 | 2.12 | 2.73 | 2.75 | 2.5 | 3.84 | 6.57 | 4.06 | 5.16 |
| Other non-operating income | -2.4 | -6.88 | -4.04 | 1.56 | -13.4 | -3.02 | 14.1 | 6.16 | -1.72 | -5.08 |
| Pre-tax income | 78.3 | 54.7 | 115 | 178 | 139 | 166 | 132 | 160 | 117 | -61.8 |
| Income tax | 25.5 | 22.1 | 32.2 | 44.8 | 41.8 | 47.2 | 35.5 | 48.8 | 29 | -4.83 |
| Net income to minority interests | 0.08 | -0.53 | 0.13 | 0.99 | -1.35 | 0.29 | 0.75 | 0.49 | 0.43 | 0.38 |
| Net income | 52.7 | 33.1 | 82.9 | 132 | 98.6 | 118 | 95.8 | 111 | 87.6 | -57.3 |
| EBITDA | 162 | 151 | 216 | 264 | 239 | 252 | 250 | 245 | 221 | 51.8 |
| EPS, basic | 1.64 | 1.03 | 2.57 | 4.10 | 3.05 | 3.66 | 3.06 | 3.56 | 2.81 | -1.94 |
| EPS, diluted | 1.64 | 1.03 | 2.57 | 4.10 | 3.05 | 3.65 | 3.04 | 3.55 | 2.80 | -1.94 |
| Shares, basic (weighted) | 32.1 | 32.2 | 32.3 | 32.3 | 32.3 | 32.3 | 31.3 | 31.2 | 31.2 | 29.6 |
| Shares, diluted (weighted) | 32.2 | 32.2 | 32.3 | 32.3 | 32.4 | 32.5 | 31.5 | 31.3 | 31.3 | 29.6 |
| Dividend per share | 0.68 | 0.68 | 0.69 | 0.73 | 0.77 | 0.81 | 0.88 | 1.01 | 1.05 | 1.09 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 182 | 184 | 198 | 196 | 241 | 302 | 292 | 173 | 115 | 112 |
| Receivables | 171 | 203 | 223 | 218 | 188 | 192 | 200 | 288 | 247 | 235 |
| Inventory | 134 | 137 | 85.9 | 95.1 | 110 | 118 | 139 | 170 | 146 | 122 |
| Other current assets | 9.25 | 14.5 | 21.3 | 24.1 | 31.8 | 32.4 | 51 | 53.9 | 37.1 | 35 |
| Total current assets | 501 | 544 | 593 | 618 | 717 | 759 | 838 | 878 | 731 | 929 |
| Property, plant and equipment | 423 | 454 | 462 | 466 | 449 | 436 | 446 | 602 | 563 | 483 |
| Lease right-of-use assets | 18.2 | 17.7 | 14.4 | 48.5 | 50.8 | 61.7 | 11.4 | |||
| Goodwill | 160 | 167 | 164 | 181 | 188 | 182 | 178 | 180 | 176 | 163 |
| Intangible assets | 66.5 | 55.4 | 49.2 | 52.9 | 46.9 | 39.1 | 33.8 | 44.6 | 38.1 | 21.4 |
| Other non-current assets | 29.8 | 39.5 | 41.6 | 62.9 | 74.7 | 81.4 | 103 | 103 | 111 | 54.9 |
| Total assets | 1,263 | 1,361 | 1,418 | 1,474 | 1,550 | 1,556 | 1,642 | 1,835 | 1,649 | 1,719 |
| Accounts payable | 43.3 | 44.9 | 52.2 | 65.2 | 49.2 | 69 | 69.7 | 87.1 | 66.1 | 64.5 |
| Accrued liabilities | 95.2 | 106 | 129 | 126 | 125 | 124 | 126 | 143 | 142 | 139 |
| Deferred revenue | 9.03 | 5.66 | 8.21 | 6.96 | 15.2 | 7.13 | 6.09 | 33.4 | ||
| Short-term debt | 51.7 | 1.8 | 1.22 | 0.02 | 0.01 | 0 | 0 | 4.22 | 0 | 0 |
| Total current liabilities | 200 | 162 | 189 | 203 | 191 | 208 | 211 | 249 | 226 | 442 |
| Long-term debt | 433 | 514 | 524 | 424 | 398 | 350 | 439 | 453 | 319 | 456 |
| Lease liabilities | 14.4 | 13.6 | 11 | 50.2 | 50.6 | 61.1 | 7.42 | |||
| Other non-current liabilities | 107 | 102 | 88.3 | 133 | 130 | 108 | 109 | 139 | 139 | 86.9 |
| Total liabilities | 752 | 788 | 810 | 772 | 730 | 678 | 775 | 868 | 700 | 987 |
| Total debt | 485 | 516 | 525 | 424 | 398 | 350 | 439 | 457 | 319 | 456 |
| Paid-in capital | 426 | 428 | 431 | 433 | 434 | 437 | 442 | 448 | 453 | 460 |
| Retained earnings | 523 | 534 | 590 | 698 | 771 | 863 | 931 | 1,011 | 1,066 | 976 |
| Treasury stock | -257 | -257 | -257 | -256 | -256 | -280 | -365 | -365 | -379 | -567 |
| Other comprehensive income | -184 | -136 | -158 | -176 | ||||||
| Shareholders' equity | 508 | 570 | 605 | 699 | 816 | 874 | 863 | 961 | 944 | 726 |
| Minority interests | 3.77 | 3.25 | 3.03 | 4.01 | 3.8 | 3.64 | 4.49 | 5.95 | 5.41 | 5.89 |
| Total equity | 511 | 573 | 608 | 703 | 820 | 878 | 868 | 967 | 949 | 732 |
| Total liabilities and equity | 1,263 | 1,361 | 1,418 | 1,474 | 1,550 | 1,556 | 1,642 | 1,835 | 1,649 | 1,719 |
| Shares outstanding | 32.1 | 32.2 | 32.3 | 32.3 | 32.3 | 32.1 | 31.1 | 31.2 | 31.1 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 52.8 | 32.6 | 83 | 133 | 97.2 | 119 | 96.5 | 112 | 88.1 | -57 |
| Depreciation and amortization | 67.5 | 72 | 79 | 70.8 | 72.7 | 74.3 | 69 | 76.7 | 89.3 | 87.9 |
| Stock-based compensation | 6.94 | 4.72 | 10.1 | |||||||
| Deferred income tax | 1.57 | -0.48 | 5.37 | 12.4 | 11.5 | 11.8 | -8.04 | -4.3 | -12.4 | -36.3 |
| Change in receivables | -12.7 | -21.9 | -19.7 | 9.28 | 31.5 | -7.73 | -14.3 | -11 | 31.8 | -0.72 |
| Change in inventory | -12.5 | 3.09 | -0.97 | -8.92 | -13.7 | -9.94 | -24.5 | 15.1 | 14.6 | 17.6 |
| Change in payables | 2.11 | 2.91 | 9.34 | 10.5 | -15.6 | 9.49 | 8.57 | -5.67 | -3.08 | 9.17 |
| Cash from operations | 80.9 | 64.2 | 132 | 200 | 140 | 217 | 128 | 148 | 218 | 152 |
| Capital expenditures | -71.2 | -85.5 | -81.6 | -67.4 | -41.5 | -52.8 | -93.7 | -83.6 | -80.2 | -69.8 |
| Acquisitions | -187 | 0 | -30.8 | 0 | 0 | 0 | -133 | 0 | 0 | |
| Cash from investing | -254 | -87.6 | -82.9 | -98.7 | -42.4 | -53.7 | -96.3 | -218 | -80.2 | -68.3 |
| Debt issued | 236 | 115 | 26 | 45 | 75 | 8 | 162 | 78 | 146 | 272 |
| Debt repaid | -34.4 | -84 | -29.9 | -120 | -101 | -56 | -73 | -92.3 | -280 | -147 |
| Stock issued | 0.52 | 0.6 | 0.2 | 0.11 | 0.06 | 0.15 | 0.02 | 0 | 0 | |
| Share buybacks | 0 | 0 | -23.4 | -84.8 | 0 | -14.2 | -186 | |||
| Dividends paid | -21.8 | -21.9 | -21.9 | -23.3 | -24.6 | -25.9 | -26.5 | -31.2 | -32.5 | -32.5 |
| Cash from financing | 172 | 12.9 | -27.3 | -100 | -60.7 | -99.6 | -23.7 | -52.6 | -184 | -96.1 |
| Exchange rate effect | -2.8 | 12.5 | -8.31 | -3.51 | 8.58 | -3.42 | -18.5 | 4.13 | -12.6 | 8.91 |
| Net change in cash | -3.37 | 1.99 | 14 | -2.22 | 45.8 | 60.7 | -10.3 | -118 | -58.1 | -2.93 |
| Free cash flow | 9.7 | -21.3 | 50.9 | 133 | 98.8 | 165 | 34.5 | 64.5 | 138 | 82.6 |
| Interest paid | 13.7 | 16 | 18.8 | 17.4 | 15.1 | 14.9 | 16 | 18.7 | 14.7 | 24.6 |
| Income taxes paid | 23.4 | 23.7 | 28.1 | 25.9 | 25.1 | 32.5 | 50 | 54.5 | 47.3 | 42,438 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 21.1% | Gross profit / revenue. |
| Operating margin | -2.4% | Operating income / revenue. |
| EBITDA margin | 4.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -4.1% | Pre-tax income / revenue. |
| Net margin | -4.2% | Net income / revenue. |
| FCF margin | 4.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 9.9% | Cash from operations / revenue. |
| Return on equity (ROE) | -6.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -3.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | -2.1% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 18.0% | Selling, general and administrative expense / revenue. |
| Capex / revenue | 5.0% | Capital expenditures / revenue. |
| D&A / revenue | 6.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -3.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 5.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -39.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -14.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -8.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -127.5% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -76.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -40.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -26.3% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -165.4% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -169.3% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -30.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 5.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 1.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -40.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 33.8% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -3.5% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 3.8% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | 7.4% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | 7.2% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -23.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -5.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -2.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 4.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 1.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 2.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -5.7% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -2.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -1.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.24x | Current assets / current liabilities. |
| Quick ratio | 0.78x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.18x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.60x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 26.3% | Total debt / total assets. |
| Liabilities / assets | 56.1% | Total liabilities / total assets. |
| Net debt | $373.3M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 7.68x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $520.7M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 10.5% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $565.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.71x | Revenue / average total assets. |
| Fixed asset turnover | 2.62x | Revenue / average property, plant and equipment. |
| Inventory turnover | 6.61x | Cost of revenue / average inventory. |
| Days inventory | 55 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 4.85x | Revenue / average receivables. |
| Days sales outstanding | 75 days | 365 x average receivables / revenue. |
| Days payables | 28 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 102 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 51.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$1.79 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $42.80 | Revenue / diluted weighted shares. |
| FCF per share | $2.07 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $4.22 | Cash from operations / diluted weighted shares. |
| Book value per share | $26.08 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $19.78 | Tangible book value / shares outstanding. |
| Cash per share | $2.71 | (Cash + short-term investments) / shares outstanding. |
| Dividends / FCF | 53.5% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 110.8% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.73B | Share price x shares outstanding. |
| Enterprise value | $2.11B | Market cap + total debt - cash - short-term investments. |
| P/S | 1.42x | Market cap / revenue. |
| P/B | 2.32x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.06x | Market cap / tangible book value, when positive. |
| P/FCF | 29.3x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 14.4x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.72x | Enterprise value / revenue. |
| EV/EBITDA | 43.3x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 35.6x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 3.4% | Free cash flow / market cap. |
| Earnings yield | -3.0% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.8% | Dividends paid over the period / market cap. |
| Shareholder yield | 5.6% | (Dividends paid + share buybacks) / market cap. |
What was ALBANY INTERNATIONAL CORP /DE/'s revenue in fiscal 2025?
ALBANY INTERNATIONAL CORP /DE/ reported revenue of $1.18B for fiscal 2025, 3.9% lower than the year before.
Was ALBANY INTERNATIONAL CORP /DE/ profitable in fiscal 2025?
No. It reported a net loss of $57.3M.
How much free cash flow did ALBANY INTERNATIONAL CORP /DE/ generate in fiscal 2025?
Cash from operations of $152.5M minus capital expenditures of $69.8M left free cash flow of $82.6M.